Clinical aspects of sodium butyrate application in dietary treatment of bowel diseases;Kliniczne aspekty zastosowania kwasu masłowego w postȩpowaniu dietetycznym w chorobach jelit

Przeglad Gastroenterologiczny

Volumn 5, Issue 6, 2010, Pages 329-334

  Banasiewicz, Tomasz ^a   Borycka Kiciak, Katarzyna ^b   Dobrowolska Zachwieja, Agnieszka ^c   Friediger, Jerzy ^d   Kiciak, Adam ^b   Krokowicz, Piotr ^e   Małecka Panas, Ewa ^f   Pietrzak, Piotr ^d   Rydzewska, Grazyna ^g   Tarnowski, Wiesław ^b   Zabielski, Romuald ^d  

^a Kat i Klinika Chirurgii Urazowej A   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c Katedra i Klinika Alergologii   (Poland)

^d Szpitala Zakonu Bonifratrów W Krakowie ^*  (Poland)

^e Katedra I Klinika Chirurgii Ogólnej I Kolorektalnej Wydzia u Nauk O Zdrowiu   (Poland)

^f Klinika Chorób Przewodu Pokarmowego Uniwersytetu Medycznego W Odzi   (Poland)

^g Centralnego Szpitala Klinicznego MSWiA W Warszawie   (Poland)

Author keywords

Crohn's disease; Irritable bowel syndrom; Sodium butyrate

Indexed keywords

BUTYRIC ACID; DEBUTIR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

CACHEXIA; CHRONIC DISEASE; DIET THERAPY; ELDERLY CARE; ENTERITIS; HUMAN; ILEITIS; INTESTINE FUNCTION; INTESTINE RESECTION; IRRITABLE COLON; REVIEW;

EID: 78650184690     PISSN: 18955770     EISSN: 18974317     Source Type: Journal    
DOI: 10.5114/pg.2010.18476     Document Type: Review

References (25)

1. Roediger WEW. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980; 21: 793-8.
2. Roy CC, Kien CL, Bouthillier L, et al. Short-chain fatty acids: ready for prime time? Nutr Cl Prac 2006; 21: 351-66.
3. Scheppach W, Bartram P, Richter A, et al. Effect of short-chain fatty acids on the human colonic mucosa in vitro. J Parenter Enter Nutr 1992; 16: 43-8.
4. Kotunia A, Pietrzak P, Guilloteau P, et al. Kwas masłowy w przewodzie pokarmowym. Przegla̧d Gastroenterologiczny 2010; 5: 117-22.
5. Banasiewicz T, Borycka-Kiciak K, Kiciak A, et al. Kwas masłowy w zapaleniach jelit. Przegla̧d Gastroenterologiczny 2010; 5: 251-7.
6. Smyth HF Jr, Carpenter CP, Weil CS, et al. Range-finding toxicity data: list V. AMA Arch Ind Hyg Occup Med 1954; 10: 61-8.
7. Senagore AJ, MacKeigan JM, Scheider M, et al. Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum 1992; 35: 923-7.
8. Breuer RI, Soergel KH, Lashner BA, et al. Short-chain fatty acid rectal irrigation for left-side ulcerativecolitis: a randomized, placebo-controlled trial. Gastroenterology 1996; 110: 873.
9. Andoh A, Bamba T, Sasaki M. Physiological and anti-inflamatory roles of diatery fiber and butyrate in intestinal functions. J Parent Ent Nutr 1999; 23: 70-3.
10. Claus R, Günthner D, Letzguß H. Effects of feeding fat-coated butyrate on mucosal morphology and function in the small intestine of the pig. J Anim Physiol Anim Nutr 2007; 91: 312-8. (Pubitemid 47149312)
11. Thompson JS, Quigley EM, Palmer JM, et al. Luminal short-chain fatty acidsand postresection intestinal adaptation. J Parenter Enteral Nutr 1996; 20: 338-43.
12. Jeppesen PB, Mortensen PB. Enhancing bowel adaptation in short bowel syndrome. Curr Gastroenterol Rep 2002; 4: 338-47.
13. Galfi P, Bokori J. Feeding trial in pigs with a diet containing sodium n-butyrate. Acta Veterinaria Hungarica 1990; 38: 3-17.
14. D'Argenio G, Cosenza V, Delle Cave M, et al. Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology 1996; 110: 1727-34.
15. Tedelind S, Westberg F, Kjerrulf M, et al. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 2007; 13: 2826-32.
16. Meier-Ruge WA, Ammann K, Bruder E, et al. Updated results on intestinal neuronal dysplasia (IND B). Eur J Pediatr Surg 2004; 14: 384-91.
17. Peng L, He Z, Chen W, et al. Effects of butyrate on intestinal barrier function in Caco-2 cell monolayer model of intestinal barrier. Pediatr Res 2007; 61: 37-41. (Pubitemid 46352313)
18. McIntyre A, Gibson PR, Young GP. Butyrate production from diatery fiber and protection against large bowel cancer in rat model. Gut 1993; 34: 386-91. (Pubitemid 23080267)
19. Velázquez OC, Ledered HM, Rombeau JL. Butyrate and the colonocyte, implication for neoplasia. Dig Dis Sci 1996; 41: 727-39.
20. Leder A, Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 1975; 5: 319-22.
21. Atweh GF, Sutton M, Nassif I, et al. Sustained induction of fetal hemoglobin by pulse butyrate therapy in SCD. Blood 1999; 93: 1790-9.
22. Weinberg R, Ji X, Sutton M, et al. Butyrate increase the efficiency of translation of γ-globin mRNA. Blod 2005; 105: 1807-9.
23. Pinto A, Fidalgo P, Cravo M, et al. Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: randomized, double-blind, controlled trial. Dis Colon Rectum 1999; 42: 788-95; discussion 795-6.
24. Al-Sabbagh R, Sinicrope F, Sellin J, et al. Short-chain fatty acid (SCFA) enemas for radiation colitis. Gastroenterology 1994; 106: A2.
25. Mamel JJ, Chen M, Combs W, et al. Short-chain fatty acid (SCFA) enema are useful for treatment of chronic radiation proctitis (CRP). Gastroenterolgy 1995; 108: A305.